Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer

The efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small-cell lung cancer (NSCLC) might depend on the presence of emphysema, but this association is not established. We aimed to investigate if quantitively and automatically measuring emphysema can predict the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Noda, Yoshimi, Shiroyama, Takayuki, Masuhiro, Kentaro, Amiya, Saori, Enomoto, Takatoshi, Adachi, Yuichi, Hara, Reina, Niitsu, Takayuki, Naito, Yujiro, Miyake, Kotaro, Koyama, Shohei, Hirata, Haruhiko, Nagatomo, Izumi, Takeda, Yoshito, Kumanogoh, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133115/
https://www.ncbi.nlm.nih.gov/pubmed/35614345
http://dx.doi.org/10.1038/s41598-022-13131-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133115/
https://www.ncbi.nlm.nih.gov/pubmed/35614345
http://dx.doi.org/10.1038/s41598-022-13131-2

Ejemplares similares